Discovery of dipiperidines as new antitubercular agents

As part of our ongoing research effort to develop new therapeutics for treatment of tuberculosis (TB), we synthesized a combinatorial library of 10,358 compounds on solid support using a pool-and-split technique and tested the resulting compounds for activity against Mycobacterium tuberculosis. Stru...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 20; no. 1; pp. 201 - 205
Main Authors Bogatcheva, Elena, Hanrahan, Colleen, Chen, Ping, Gearhart, Jacqueline, Sacksteder, Katherine, Einck, Leo, Nacy, Carol, Protopopova, Marina
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 01.01.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:As part of our ongoing research effort to develop new therapeutics for treatment of tuberculosis (TB), we synthesized a combinatorial library of 10,358 compounds on solid support using a pool-and-split technique and tested the resulting compounds for activity against Mycobacterium tuberculosis. Structure–activity relationship (SAR) evaluation identified new compounds with antitubercular activity, including a novel hit series that is structurally unrelated to any existing antitubercular drugs, dipiperidines. Dipiperidine representatives exhibited MIC values as low as 7.8 μM, the ability to induce promoter Rv0341 activated in response to cell wall biosynthesis inhibition, relatively low nonspecific cellular toxicity in the range of 30–162 μM, and log P values less than 4.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: John Hopkins School of Medicine & John Hopkins School of Public Health, Baltimore, MD, USA
Present address: Aeras Global TB Vaccine Foundation, 1405 Research Blvd., Rockville, MD 20850, USA
Corresponding author. Tel.: +1 301-762-7776; fax: 301-762-7778; elenabogatcheva@sequella.com
Present address: National Institute of Health (NIH), NIAID, 6610 Rockledge Dr., Bethesda MD, USA
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2009.10.135